GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Theratechnologies Inc (NAS:THTX) » Definitions » Additional Paid-In Capital

Theratechnologies (Theratechnologies) Additional Paid-In Capital : $23.87 Mil(As of Feb. 2024)


View and export this data going back to 2011. Start your Free Trial

What is Theratechnologies Additional Paid-In Capital?


Theratechnologies's quarterly additional paid-in capital increased from Aug. 2023 ($22.79 Mil) to Nov. 2023 ($23.18 Mil) and increased from Nov. 2023 ($23.18 Mil) to Feb. 2024 ($23.87 Mil).

Theratechnologies's annual additional paid-in capital increased from Nov. 2021 ($12.84 Mil) to Nov. 2022 ($18.81 Mil) and increased from Nov. 2022 ($18.81 Mil) to Nov. 2023 ($23.18 Mil).

Theratechnologies Additional Paid-In Capital Historical Data

The historical data trend for Theratechnologies's Additional Paid-In Capital can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Theratechnologies Additional Paid-In Capital Chart

Theratechnologies Annual Data
Trend Nov14 Nov15 Nov16 Nov17 Nov18 Nov19 Nov20 Nov21 Nov22 Nov23
Additional Paid-In Capital
Get a 7-Day Free Trial Premium Member Only Premium Member Only 10.78 12.07 12.84 18.81 23.18

Theratechnologies Quarterly Data
May19 Aug19 Nov19 Feb20 May20 Aug20 Nov20 Feb21 May21 Aug21 Nov21 Feb22 May22 Aug22 Nov22 Feb23 May23 Aug23 Nov23 Feb24
Additional Paid-In Capital Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 19.44 20.15 22.79 23.18 23.87

Theratechnologies Additional Paid-In Capital Calculation

Capital that a company raises in a financing round in excess of the capital's par value. The account represents the excess paid by an investor over the par-value price of a stock issue. Additional paid-in-capital can arise from issuing either preferred or common stock.

Additional Paid-In Capital is calculated as

Additional Paid-In Capital=(Issue Price-Par Value)* Shares Outstanding (Diluted Average)

Theratechnologies Additional Paid-In Capital Related Terms

Thank you for viewing the detailed overview of Theratechnologies's Additional Paid-In Capital provided by GuruFocus.com. Please click on the following links to see related term pages.

Theratechnologies (Theratechnologies) Business Description

Industry
GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Theratechnologies Inc (NAS:THTX) » Definitions » Additional Paid-In Capital
Comparable Companies
TSX:SVA TSXV:MIR XCNQ:METX TSXV:ARCH XCNQ:DTC TSX:MSCL TSX:ONC XCNQ:ACOG TSX:HBP TSX:MBX OCSE:NOVO B VRTX REGN ASX:CSL MRNA XKRX:207940 XKRX:068270 XBRU:UCB BNTX XBRU:ARGX
Traded in Other Exchanges
TQ80:Germany TH:Canada
Address
2015, rue Peel, 11e etage, Montreal, QC, CAN, H3A 1T8
Website
https://www.theratech.com
Theratechnologies Inc is a specialty pharmaceutical company that addresses the unmet medical needs of HIV patients. It mainly operates in Canada and the United States. The company has two approved products, EGRIFTA marketed in Canada and the United States, and Trogarzo approved for commercialization in the United States.